Details for New Drug Application (NDA): 011359
✉ Email this page to a colleague
NDA 011359 describes ORA-TESTRYL, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the ORA-TESTRYL profile page.
The generic ingredient in ORA-TESTRYL is fluoxymesterone. There are three drug master file entries for this compound. Additional details are available on the fluoxymesterone profile page.
The generic ingredient in ORA-TESTRYL is fluoxymesterone. There are three drug master file entries for this compound. Additional details are available on the fluoxymesterone profile page.
Summary for 011359
| Tradename: | ORA-TESTRYL |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | fluoxymesterone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011359
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
